PMCTPharmaCountry
    Inicio

Actualizaciones regulatorias

Novedades regulatorias de FDA, EMA, TGA y organismos globales

#Alendronate ×

UPDATED
Actualizaciones regulatorias
25 sept 2026•1 min de lectura
FDA Approves ANDA 076768 for Alendronate Sodium Tablets
The FDA has granted approval for an Abbreviated New Drug Application (ANDA) 076768 covering multiple strengths of alendronate sodium tablets, manufactured by Exelan Pharmaceuticals and Cipla USA.